Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stenzl

Showing results (351-360 of 925) with videos related to

Pageof 93
Sort By:
Asian Journal of Andrology|December 30, 2017
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancerMiriam Hegemann, Moritz Maas, Steffen Rausch, et al.
Seminars in Urologic Oncology|March 15, 2001
Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversionA Hobisch, K Tosun, J Kinzl, et al.
Der Urologe. Ausg. A|June 29, 2005
[Free and pedicled muscle transfer as a therapy option in urological surgery]E Hoefter, C Holm, U Dornseifer, et al.
Cancer Letters|November 10, 2011
Thymidine kinase and cancer monitoringStefan Aufderklamm, Tilman Todenhöfer, Georgios Gakis, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1987
Positive end-expiratory pressure and the damaged right ventricle. An experimental open versus closed chest studyH H Metzler, W Stenzl, P H Rehak, et al.
Translational Andrology and Urology|November 22, 2021
Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastasesStefan Aufderklamm, Jörg Hennenlotter, Steffen Rausch, et al.
World Journal of Urology|February 26, 2022
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapiesViktoria Stühler, Lisa Herrmann, Moritz Maas, et al.
World Journal of Urology|January 20, 2024
Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinomaViktoria Stühler, Bilal Alemi, Steffen Rausch, et al.
World Journal of Urology|February 11, 2021
Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURBTilman Todenhöfer, Moritz Maas, Miriam Ketz, et al.
Nature Reviews. Urology|May 28, 2020
Author Correction: Regenerative medicine and injection therapies in stress urinary incontinenceChristopher J Hillary, Sabiniano Roman, Sheila MacNeil, et al.
Pageof 93

Showing results (351-360 of 925) with videos related to

Sort By:
Pageof 93
Asian Journal of Andrology|December 30, 2017
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancerMiriam Hegemann, Moritz Maas, Steffen Rausch, et al.
Seminars in Urologic Oncology|March 15, 2001
Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversionA Hobisch, K Tosun, J Kinzl, et al.
Der Urologe. Ausg. A|June 29, 2005
[Free and pedicled muscle transfer as a therapy option in urological surgery]E Hoefter, C Holm, U Dornseifer, et al.
Cancer Letters|November 10, 2011
Thymidine kinase and cancer monitoringStefan Aufderklamm, Tilman Todenhöfer, Georgios Gakis, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 1, 1987
Positive end-expiratory pressure and the damaged right ventricle. An experimental open versus closed chest studyH H Metzler, W Stenzl, P H Rehak, et al.
Translational Andrology and Urology|November 22, 2021
Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastasesStefan Aufderklamm, Jörg Hennenlotter, Steffen Rausch, et al.
World Journal of Urology|February 26, 2022
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapiesViktoria Stühler, Lisa Herrmann, Moritz Maas, et al.
World Journal of Urology|January 20, 2024
Analysis of the immunological markers BTLA, TIM-3, and PD-L1 at the invasion front and tumor center in clear cell renal cell carcinomaViktoria Stühler, Bilal Alemi, Steffen Rausch, et al.
World Journal of Urology|February 11, 2021
Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURBTilman Todenhöfer, Moritz Maas, Miriam Ketz, et al.
Nature Reviews. Urology|May 28, 2020
Author Correction: Regenerative medicine and injection therapies in stress urinary incontinenceChristopher J Hillary, Sabiniano Roman, Sheila MacNeil, et al.
Pageof 93